Drain/inj joint/bursa w/us
CPT 20604 covers draining fluid from or injecting medication into a joint or bursa (fluid-filled sac near joints) using ultrasound guidance to ensure accurate needle placement. This imaging guidance helps the provider target the exact location for treatment.
This calculator gives a typical-case estimate using standard Medicare modifier rules. Actual payment depends on payer policies, documentation, code-specific CMS status indicators, and locality. Verify before billing.
RVU breakdown
Conversion factor: 32.3465 · Source: CMS MPFS RVU25A · Confidence: High
NCCI bundling edits
Loading bundling edits…
Billing tips
Always document and retain permanent ultrasound images with measurements and annotations to justify imaging guidance over CPT 20605 (non-ultrasound)
Impact: Prevents $35.91 downcoding loss (difference between $80.87 for 20604 vs approximately $44.96 for 20605 non-facility rates); images must be stored in patient record per CPT definition
Bill facility vs. non-facility rates correctly based on actual place of service; verify your practice setting designation with Medicare
Impact: $35.91 difference between non-facility ($80.87) and facility ($44.96) rates; incorrect POS codes trigger recoupment audits
When billing multiple joint injections, use anatomic modifiers and modifier 59 to identify each distinct site; do not simply bill multiple units without modifiers
Impact: Prevents automatic denials of additional units; each additional distinct site can yield $80.87 additional reimbursement when properly coded
Document medical necessity for ultrasound guidance specifically (obesity, previous failed blind attempts, complex anatomy, need for effusion confirmation)
Impact: Reduces appeal time and denial rates; lack of documented rationale for imaging accounts for 40-60% of 20604 denials requiring downcode to 20605
Separately bill for medication injected using appropriate J-codes or HCPCS codes; these are not included in the procedure reimbursement
Impact: Recovers $20-200 additional per procedure depending on medication (corticosteroids, hyaluronic acid, etc.); commonly overlooked revenue source
Verify that E/M services billed with modifier 25 on the same date document a separate, significant medical decision beyond the procedure indication
Real billers contribute denial patterns and appeal strategies for this code. Once 5+ reports come in, you’ll see live aggregated data here — the only place this exists, free.
Get the free Revenue Protection Toolkit — the denial triggers, modifier pitfalls, and bundling conflicts that quietly cost you reimbursement. Instant download.
Help build the field knowledge
MedPayIQ gets smarter as billers contribute. If you've had this code denied, share what happened so others learn from it. Anonymous, no patient info.